Skip to content
healthcare.dev

TUKYSA

NDC 51144-001, tucatinib, tablet, from SEAGEN INC..

Product NDC
51144-001
Status
Listed
Labeler
SEAGEN INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213411
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51144-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TUCATINIB50 mg/1

Pharmacologic classes

Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; Tyrosine Kinase Inhibitors [MoA]

Package NDCNDC-11Package
51144-001-605114400016060 TABLET in 1 BOTTLE (51144-001-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f27eb1b9-b7fc-424e-988f-84dd7bb195a3

Use it

Look up 51144-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51144-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51144-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.